Commercial immunoglobulin products now contain neutralising antibodies against SARS-CoV-2 spike antibody which are detectable in patient serum
Vinit Upasani, Mary O’Sullivan, Fernando Moreira, Sarita Workman, Andrew Symes, Siobhan O Burns, Susan Tadros, View ORCID ProfileLaura McCoy, David M Lowe
doi: https://doi.org/10.1101/2022.09.22.22280216
Vinit Upasani
1Institute of Immunity and Transplantation, University College London, London, UK
Mary O’Sullivan
2Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, UK
Fernando Moreira
2Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, UK
Sarita Workman
2Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, UK
Andrew Symes
2Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, UK
Siobhan O Burns
1Institute of Immunity and Transplantation, University College London, London, UK
2Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, UK
Susan Tadros
2Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, UK
Laura McCoy
1Institute of Immunity and Transplantation, University College London, London, UK
David M Lowe
1Institute of Immunity and Transplantation, University College London, London, UK
2Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, UK
Data Availability
All data produced in the present work are contained in the manuscript.
Posted September 23, 2022.
Commercial immunoglobulin products now contain neutralising antibodies against SARS-CoV-2 spike antibody which are detectable in patient serum
Vinit Upasani, Mary O’Sullivan, Fernando Moreira, Sarita Workman, Andrew Symes, Siobhan O Burns, Susan Tadros, Laura McCoy, David M Lowe
medRxiv 2022.09.22.22280216; doi: https://doi.org/10.1101/2022.09.22.22280216
Commercial immunoglobulin products now contain neutralising antibodies against SARS-CoV-2 spike antibody which are detectable in patient serum
Vinit Upasani, Mary O’Sullivan, Fernando Moreira, Sarita Workman, Andrew Symes, Siobhan O Burns, Susan Tadros, Laura McCoy, David M Lowe
medRxiv 2022.09.22.22280216; doi: https://doi.org/10.1101/2022.09.22.22280216
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (196)
- Cardiovascular Medicine (2877)
- Dermatology (245)
- Emergency Medicine (432)
- Epidemiology (12600)
- Forensic Medicine (10)
- Gastroenterology (811)
- Genetic and Genomic Medicine (4474)
- Geriatric Medicine (407)
- Health Economics (717)
- Health Informatics (2867)
- Health Policy (1057)
- Hematology (378)
- HIV/AIDS (907)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (465)
- Neurology (4233)
- Nursing (226)
- Nutrition (619)
- Oncology (2218)
- Ophthalmology (630)
- Orthopedics (255)
- Otolaryngology (322)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (489)
- Pediatrics (1182)
- Primary Care Research (485)
- Public and Global Health (6817)
- Radiology and Imaging (1501)
- Respiratory Medicine (906)
- Rheumatology (430)
- Sports Medicine (373)
- Surgery (475)
- Toxicology (59)
- Transplantation (204)
- Urology (175)